Glenmark Pharmaceuticals submits press release
Glenmark Pharmaceuticals has submitted press release stating that Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg.
The above information is a part of company’s filings submitted to BSE.
